Signal Transduction Pathways Through TRK-A and TRK-B Receptors in Human Neuroblastoma Cells

Overview

Journal Jpn J Cancer Res

Specialty Oncology

Date 2001 Feb 27

PMID 11223544

Citations 19

Authors

T Sugimoto

H Kuroda

Y Horii

H Moritake

T Tanaka

S Hattori

Affiliations

Soon will be listed here.

Abstract

Little is known about the signal transduction pathways of TRK family receptors in neuroblastoma (NB) cells. In this study, an NB cell line, designated MP-N-TS, was established from an adrenal tumor taken from a 2-year-old boy. This cell line expressed both TRK-A and TRK-B receptors, which is rare in a single NB cell line. Therefore, the MP-N-TS cell line was used to determine whether the signal transduction through these constitutive receptors is functional. Three neurotrophins, nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and neurotrophin-4 / 5 (NT-4 / 5), induced tyrosine phosphorylation of panTRK, and BDNF and NT-4 / 5 induced tyrosine phosphorylation of TRK-B. Tyrosine phosphorylation of panTRK and / or TRK-B by the neurotrophins was inhibited in the presence of a tyrosine kinase inhibitor K252a. Tyrosine phosphorylation of Src homologous and collagen (Shc), extracellular signal-regulated kinase (ERK)-1 and ERK-2, and phospholipase C-gamma1 (PLC-gamma1) was increased by the three neurotrophins and the increase was inhibited in the presence of K252a. Activation of Ras, detected as the GTP-bound form of Ras, was induced by the three neurotrophins. The neurotrophins did not modulate the expressions of TRK-A or TRK-B mRNA, but they did induce the expression of c-fos mRNA. Exogenous NGF induced weak neurite outgrowth, whereas exogenous BDNF and NT-4 / 5 induced distinct neurite outgrowth. Exogenous BDNF and NT-4 / 5 increased the number of viable cells, while NGF did not. Our results demonstrate that the signal transduction pathways through TRK-A and TRK-B in MP-N-TS cells are functional and similar, and the main downstream signaling pathways from the three neurotrophins are mitogen-activated protein kinase (MAPK) cascades through Shc, activated Ras, ERK-1 and ERK-2, and the transduction pathway through PLC-gamma1. Further, BDNF and NT-4 / 5 increased cell viability. The MP-N-TS cell line should be useful for clarifying the TRK-A and TRK-B signaling pathways responsible for the different prognoses in patients with NB.

Citing Articles

Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington's disease.

Shafie A, Ashour A, Anwar S, Anjum F, Hassan M Arch Pharm Res. 2024; 47(6):571-595.

PMID: 38764004 DOI: 10.1007/s12272-024-01499-w.

The role of sphingosine-1-phosphate in the development and progression of Parkinson's disease.

Wang W, Zhao Y, Zhu G Front Cell Neurosci. 2024; 17:1288437.

PMID: 38179204 PMC: 10764561. DOI: 10.3389/fncel.2023.1288437.

The factors affecting neurogenesis after stroke and the role of acupuncture.

Mu J, Ma L, Zhang Z, Qian X, Zhang Q, Ma L Front Neurol. 2023; 14:1082625.

PMID: 36741282 PMC: 9895425. DOI: 10.3389/fneur.2023.1082625.

The Role of SliTrk5 in Central Nervous System.

Liu Y, Zhang L, Mei R, Ai M, Pang R, Xia D Biomed Res Int. 2022; 2022:4678026.

PMID: 35872846 PMC: 9303146. DOI: 10.1155/2022/4678026.

New Avenues for the Treatment of Huntington's Disease.

Kim A, Lalonde K, Truesdell A, Gomes Welter P, Brocardo P, Rosenstock T Int J Mol Sci. 2021; 22(16).

PMID: 34445070 PMC: 8394361. DOI: 10.3390/ijms22168363.

References

Matsumura I, Nakajima K, Wakao H, Hattori S, Hashimoto K, Sugahara H . Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol Cell Biol. 1998; 18(7):4282-90. PMC: 109012. DOI: 10.1128/MCB.18.7.4282. View

Tapley P, Lamballe F, Barbacid M . K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene. 1992; 7(2):371-81. View

de Rooij J, Bos J . Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene. 1997; 14(5):623-5. DOI: 10.1038/sj.onc.1201005. View

Lautenberger J, Ulsh L, Shih T, Papas T . High-level expression in Escherichia coli of enzymatically active Harvey murine sarcoma virus p21ras protein. Science. 1983; 221(4613):858-60. DOI: 10.1126/science.6308763. View

Nakagawara A, Scavarda N, Azar C, Cantor A, Brodeur G . Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med. 1993; 328(12):847-54. DOI: 10.1056/NEJM199303253281205. View

Matsumura T, Sugimoto T, Sawada T, Amagai T, Negoro S, Kemshead J . Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8). Cancer Res. 1987; 47(11):2924-30. View

Nakagawara A, Azar C, Scavarda N, Brodeur G . Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol. 1994; 14(1):759-67. PMC: 358424. DOI: 10.1128/mcb.14.1.759-767.1994. View

Ip N, Stitt T, Tapley P, Klein R, Glass D, Fandl J . Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron. 1993; 10(2):137-49. DOI: 10.1016/0896-6273(93)90306-c. View

Muroya K, Hattori S, Nakamura S . Nerve growth factor induces rapid accumulation of the GTP-bound form of p21ras in rat pheochromocytoma PC12 cells. Oncogene. 1992; 7(2):277-81. View

10.

Sugimoto T, Sawada T, Matsumura T, Kemshead J, Ishii T, Horii Y . Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient. Cancer Res. 1986; 46(9):4765-9. View

11.

Lucarelli E, KAPLAN D, Thiele C . Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells. Eur J Cancer. 1998; 33(12):2068-70. DOI: 10.1016/s0959-8049(97)00266-9. View

12.

Matsumoto K, Wada R, Yamashiro J, Kaplan D, Thiele C . Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res. 1995; 55(8):1798-806. View

13.

Sugimoto T, Sawada T, Matsumura T, Horii Y, Kemshead J, Suzuki Y . Morphological differentiation of human neuroblastoma cell lines by a new synthetic polyprenoic acid (E5166). Cancer Res. 1987; 47(20):5433-8. View

14.

SHIKATA A, Sugimoto T, Hosoi H, Sotozono Y, Shikata T, Sawada T . Increased expression of trk proto-oncogene by gamma-interferon in human neuroblastoma cell lines. Jpn J Cancer Res. 1994; 85(2):122-6. PMC: 5919423. DOI: 10.1111/j.1349-7006.1994.tb02070.x. View

15.

Stephens R, Loeb D, Copeland T, Pawson T, Greene L, Kaplan D . Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses. Neuron. 1994; 12(3):691-705. DOI: 10.1016/0896-6273(94)90223-2. View

16.

Kogner P, Barbany G, Dominici C, Castello M, Raschella G, Persson H . Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Cancer Res. 1993; 53(9):2044-50. View

17.

Middlemas D, Kihl B, Zhou J, Zhu X . Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells. J Biol Chem. 1999; 274(23):16451-60. DOI: 10.1074/jbc.274.23.16451. View

18.

Sugimoto T, Ueyama H, Hosoi H, Inazawa J, Kato T, Kemshead J . Alpha-smooth-muscle actin and desmin expressions in human neuroblastoma cell lines. Int J Cancer. 1991; 48(2):277-83. DOI: 10.1002/ijc.2910480221. View

19.

Kaplan D, Stephens R . Neurotrophin signal transduction by the Trk receptor. J Neurobiol. 1994; 25(11):1404-17. DOI: 10.1002/neu.480251108. View

20.

Yamada M, Ohnishi H, Sano S, Nakatani A, Ikeuchi T, Hatanaka H . Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in response to brain-derived neurotrophic factor in cultured cerebral cortical neurons. J Biol Chem. 1997; 272(48):30334-9. DOI: 10.1074/jbc.272.48.30334. View